EORTC organised the 5th EORTC Quality of Life event held in Brussels on 16-17 May 2019. The event brought together more than 200 people from 30 countries to learn about the latest topics in quality of life (QOL) and patient reported outcomes research.
Over 30 of the world’s most influential QOL researchers presented current state-of-the-art methods for instrument development and QOL measurement in international cancer clinical trials, addressing a variety of topics from designing robust measures to understanding their clinical meaning. There were discussions on new tools and emerging technologies that have the potential to change the way we measure QOL, as well as on the rapidly growing field of electronic questionnaire administration.
Dr. Andrew Bottomley (Conference Chair & Head of the EORTC QoL department) said this meeting showed “how far the field of QOL has advanced in the recent years. We heard regulators, payers and academics working hard to make the best of use of patients’ views to better understand the impact and value of new cancer treatments”